HPLC purity testing for peptides

What the method does

In reversed-phase HPLC the sample is carried in a mobile phase through a column packed with a non-polar stationary phase. Components separate by how strongly they partition into that phase, which for peptides tracks closely with hydrophobicity. A detector at the column outlet records what emerges and when.

The output is a chromatogram: a trace with a peak for each species the detector saw. The target peptide is identified by its retention time, and purity is reported as that peak's area as a percentage of the total.

What the impurities are

In a synthetic peptide the impurity profile is a record of what went slightly wrong during assembly. Deletion sequences where a coupling step did not go to completion, truncated chains, species where a protecting group was not fully removed, and oxidation or deamidation products formed after synthesis.

These are structurally similar to the target, which is precisely why a separation method is needed to see them and why the quality of the separation determines the quality of the number.

Why the wavelength is part of the result

Peptide bonds absorb in the far ultraviolet, so purity is commonly measured at 214 or 220 nm. Aromatic residues — tryptophan, tyrosine, phenylalanine — absorb around 280 nm, so a measurement at that wavelength sees a different picture and is not comparable.

A purity figure quoted without its wavelength is quoting the number without the measurement. Two suppliers reporting 98% at different wavelengths have not reported the same thing.

What HPLC purity does not tell you

• It does not confirm identity. A pure peak of the wrong molecule is still a pure peak, which is why mass spectrometry runs alongside it.
• It does not report anything that does not absorb at the detection wavelength, which includes residual water and counter-ions such as trifluoroacetate.
• It is therefore not net peptide content. A 99% pure lot can still be well under its label weight in actual peptide mass.
• It says nothing about endotoxin, heavy metals or residual solvents, each of which is a separate test.

Where HPLC is not the right method

Reversed-phase HPLC suits short synthetic sequences well. Larger recombinant proteins are a different problem: conformation matters, aggregation is a real impurity class, and size-exclusion methods report things reversed-phase cannot see. A multi-component blend is different again, because the question stops being how pure a single peak is and becomes how much of each named component is present.

Why third-party matters more than the number

An in-house purity figure is a self-assessment. The same measurement performed by an independent analytical laboratory is checkable by someone with no commercial interest in the answer, and it is attributable — the certificate names who ran it.

In a category with a documented trust problem, who measured it is a more informative question than what the number was.

Common questions

What does 99% purity by HPLC mean?

That the target peptide accounted for 99% of the total peak area the detector recorded, at the wavelength stated in the method. It is a proportion of what was detected, not a proportion of the vial's mass.

Is HPLC purity the same as net peptide content?

No, and conflating them is the most common misreading of a certificate. Purity is the target's share of the detected peaks; net content is the actual mass of peptide in the vial, which excludes water and counter-ions.

Why is mass spectrometry needed if HPLC shows high purity?

Because HPLC measures how much of one species is present, not which species it is. Mass spectrometry confirms the molecule is the one named, and a purity figure for an unconfirmed compound is not worth much.

Should purity be tested per lot?

Yes. Purity is a property of a batch of material, so a figure carried forward from a previous lot describes material the purchaser does not have.